Blog / Archives
Rayno Life Science Portfolios: 2011 Movers-Ardea (RDEA),Immucor (BLUD)
We will be attending the JPMorgan Healthcare Conference in San Francisco next week looking for new ideas. Healthcare overall has been a laggard (up 1.87% vs 11.47% S&P for one year period) but...
Rayno Life Science Portfolios: 2010 Performance
Diagnostics and Tools 2010 Original Price Price % Ret Recomm YrEnd'10 Abaxis ABAX 2/2/09 15 26.85 79 CardioV.Sys. CSII 11/5/10 7.15 11.66 63 Celera CRA 3/28/10 7 6.3 -10 Exact Sci EXAS 12/10/10 5.6...
Who Knew “Land Banks” Were Off-Balance Sheet?
It was 2005, the peak of the housing bubble and housing stocks were running wild. Toll Brothers (TOL) and Lennar (LEN) stock were at 60. There was no end to housing with Wall Street buying up...
Rayno Life Science Portfolios 2010- Another Excellent Year!
The Life Science Sector (^BTK) Overall Has Outperformed Other Major Market Indices Over 10 Years As we approach year-end we can look back on a great year for all markets and outperformance for the...
‘Tis the Season for Microcaps: Corgenix(CONX.OB), ImmuCell (ICCC) and IVAX (IVD)
Three Value Stocks Off The Radar Screen At this time of the year, especially when the market has a bullish tone, small (IWM) and mid cap (MDY) stocks are likely to outperform-YTD they are up about...
Vermillion Soars on a Quiet Day: VRML $9 Up 23.2%
Vermillion (VRML) continues its wild ride upward from the November low of $4.53 on heavy volume of 546K shares with no apparent news. Two analysts cover the stock with a buy/outperform and Revenue...
Rayno Snow Blog (La Nina Advisory) and Nat Gas Update (Bearish)
Yes there is snow everywhere in California and more to come. Mammoth has 161" month to date an all time record and 11-16 feet over past several days. Season TD snow is 255". Weather Geek :...
Another Good Day for Biotech Stocks:Incyte(INCY), Martek(MATK) and XBI
Clinical News and M&A Boost Biotechs Biotech stocks continued their seasonal strength with many winners in the mid-cap sector. Our index of 33 mid-cap stocks was up 2.7% which is unusually...
Weekly News Update: Dx Patents, XMRV, Avastin, Healthcare Reform
Significant Life Science News This Week Diagnostic Tests Can Be Patented, U.S. Court Rules - Bloomberg New Blood-Screening Advised - WSJ.com WABE: FDA Rules On Avastin Breast Cancer Drug...
Biotech Rally Rolls On-Intermune (ITMN) Up 130%
Biotech Outperforms Large Cap Pharma Biotechnology stocks were up today sparked by Intermune (ITMN $32.74)news that the Committee for Medicinal Products for Human Use (CHMP) of the European...